Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Sonny7on Mar 09, 2020 4:42pm

60 Views

Post# 30785273

RE:RE:RE:RE:RE:Gilead buys Forty Seven Inc U$4.9 billion: phase 1b trial

Yes. Big pharma pays in USD. With the weakness of current CAD value, there would be at least a 25% premium to Canadian shareholders if one of them decided to slap us silly with their chequebook

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal